Application 020162
- Type
- BLA
- Sponsor
- FERRING
Purple Book Biologic Products#
BLA, Proprietary name, Proper name table| BLA | Proprietary name | Proper name | License type | Status | Latest source |
|---|
| 020162 | Acthrel | corticorelin ovine triflutate | 351(a) | Disc | 2026-07-01 |
Application Products#
Product, Drug, Ingredient table| Product | Drug | Ingredient | Form | Strength | Reference drug | Reference standard |
|---|
| 001 | ACTHREL | CORTICORELIN OVINE TRIFLUTATE | INJECTABLE;INJECTION | EQ 0.1MG BASE/VIAL | No | No |
NDC Listings For This Application#
NDC listings for this application page 1 of 1 ยท 5 matching rows.
NDC, Name, Nonproprietary name table| NDC | Name | Nonproprietary name | Labeler | Marketing category | Status |
|---|
| 55566-0302 | Acthrel | Corticorelin ovine triflutate | Ferring Pharmaceuticals Inc. | BLA | Current |
| 55566-0302 | Acthrel | Corticorelin ovine triflutate | Ferring Pharmaceuticals Inc. | NDA | Current |
| 55566-0302 | Acthrel | Corticorelin ovine triflutate | Ferring Pharmaceuticals Inc. | BLA | Current |
| 55566-0302 | Acthrel | Corticorelin ovine triflutate | Ferring Pharmaceuticals Inc. | NDA | Current |
| 55566-0302 | Acthrel | Corticorelin ovine triflutate | Ferring Pharmaceuticals Inc. | BLA | Current |
Documents#
Document, Submission type, Date table| Document | Submission type | Date |
|---|
| 62257 | APPL | 2020-03-23 |
| 12283 | SUPPL | 2020-03-23 |
| 2110 | SUPPL | 2020-03-23 |